🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

4,196 results for “GE” Clear

  1. Telmisartan

    Boehringer Ingelheim

    Cardiovascular Diseases

    approved small molecule completed

    1 trial

  2. Terrosa 20 micrograms/80 microliters solution for injection in pre-filled pen, Acido Alendronico Aurobindo 70 mg compresse

    Gedeon Richter Australia Pty Ltd

    Prevention of new morphometric vertebral fractures and/or worsening of previous vertebral fractures.

    approved small molecule active

    1 trial

  3. The Placebo used for the clinical trial is a sterile saline solution (0.9% w/v solution of NaCl in water) supplied in 1.25 mL pre-filled glass syringes., Shingrix suspension for injection in pre filled syringe Herpes zoster vaccine (recombinant, adjuvanted), Shingrix powder and suspension for suspension for injection Herpes zoster vaccine (recombinant, adjuvanted)

    GlaxoSmithKline

    Incident dementia

    approved small molecule active

    1 trial

  4. Tigecycline

    Wyeth is now a wholly owned subsidiary of Pfizer

    Skin Diseases, Bacterial

    approved small molecule completed

    1 trial

  5. Tislelizumab + cisplatin + paclitaxel

    The First People's Hospital of Lianyungang

    Esophageal Squamous Cell Carcinoma

    approved small molecule active

    1 trial

  6. Toripalimab

    Coherus Oncology

    Nasopharyngeal Cancer Recurrent

    approved small molecule active

    1 trial

  7. Tranexamic Acid

    The First People's Hospital of Lianyungang

    Postpartum Hemorrhage， Cesarean Section

    approved small molecule active

    1 trial

  8. Tranexamic Acid 1000 mg/10ml normal saline infusion

    United Therapeutics Europe Ltd

    Postpartum Hemorrhage

    approved small molecule terminated

    1 trial

  9. Trangorex 200 mg comprimidos

    The George Institute

    Atrial fibrillation

    approved small molecule active

    1 trial

  10. Ultomiris 300 mg/30 mL concentrate for solution for infusion

    The George Institute

    IgA nephropathy

    approved small molecule active

    1 trial

  11. Urapidil Accord 5 mg/ml solución inyectable y para perfusión EFG, Trandate 5mg/ml Solution for Injection, Fenilefrina Altan 0,1 mg/ml solución inyectable y para perfusión.

    The George Institute

    Acute Ischemic Stroke

    approved small molecule active

    1 trial

  12. VYDURA 75 mg oral lyophilisate, Placebo for Rimegepant 75 mg

    Pfizer Australia Pty Ltd

    Migraine attacks with or without aura

    approved small molecule active

    1 trial

  13. Vabysmo 120 mg/mL solution for injection

    Hoffmann-La Roche

    Neovascular Age-Related Macular Degeneration

    approved small molecule active

    1 trial

  14. Vabysmo 120 mg/mL solution for injection in pre-filled syringe

    The George Institute

    SUBRETINAL HYPERREFLECTIVE MATERIAL

    approved small molecule active

    1 trial

  15. Vaxigrip Tetra, suspensie voor injectie in een voorgevulde spuit Quadrivalent griepvaccin (gesplitst virion, geïnactiveerd), Fluenz Tetra nasal spray suspension Influenza vaccine (live attenuated, nasal)

    Disc Medicine

    healthy individuals

    approved small molecule active

    1 trial

  16. Video directly observed therapy with contingency management

    BRIGHT MINDS BIOSCIENCES INC.

    HIV Infections

    approved other active

    1 trial

  17. Vortioxetine 10 mg

    Takeda

    Age-related Cognitive Decline

    approved small molecule completed

    1 trial

  18. Vyvgart 20 mg/mL concentrate for solution for infusion

    The George Institute

    Patients affected by generalized myasthenia gravis

    approved small molecule active

    1 trial

  19. Wegovy 2.4 mg solution for injection in pre-filled pen

    The George Institute

    obstructive sleep apnea

    approved small molecule active

    1 trial

  20. XELJANZ 11 mg prolonged-release tablets

    Disc Medicine

    Rheumatoid arthritis or psoriatic arthritis according to respectively 2010 criteria or CASPAR criteria

    approved small molecule active

    1 trial

  21. Xolair 150 mg solution for injection in pre-filled syringe, Physiological saline

    Disc Medicine

    Carotid artery stenosis

    approved small molecule active

    1 trial

  22. Xolair 75 mg solution for injection in pre-filled syringe

    Pari Pharma GmbH

    Well controlled severe allergic asthma

    approved small molecule active

    1 trial

  23. Xtandi - 40 mg soft capsules

    The George Institute

    PROSTATE CANCER

    approved small molecule active

    1 trial

  24. Yuflyma 40 mg solution for injection in pre-filled pen, Hyrimoz 40 mg solution for injection in pre-filled pen, Hefiya 40 mg solution for injection in pre-filled pen, Humira 40 mg solution for injection in pre-filled syringe, Humira 40 mg solution for injection in pre-filled pen, Hefiya 40 mg solution for injection in pre-filled syringe, Yuflyma 40 mg solution for injection in pre-filled syringe, Yuflyma 40 mg solution for injection in pre-filled syringe, Hyrimoz 40 mg solution for injection in pre-filled s

    Lacuna Pharma Pty Ltd

    Rheumatoid arthritis

    approved small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources